Feedback Form
Join, Follow & Connect
Join Modern Healthcare's LinkedIn group Follow Modern Healthcare on Twitter Join Modern Healthcare's Facebook group Join Modern Healthcare's Flickr group Get a Modern Healthcare news feed
 
 
Comment Buy Reprints Print Article Share on LinkedIn Share on Facebook Share on Twitter Email this page to a colleague
Healthcare Business News
 
A technician, left, screens blood of newborns at the Minnesota Public Health Laboratory. The samples of the newborns' blood are also used by researchers at the Mayo Clinic.
A technician, left, screens blood of newborns at the Minnesota Public Health Laboratory. The samples of the newborns' blood are also used by researchers at the Mayo Clinic.
Photo credit: AP

Regional News/Midwest: Permission required

Minn. court restricts use of newborn blood samples


By Paul Barr
Posted: November 21, 2011 - 12:01 am ET
Tags:

The Minnesota Supreme Court ruled against the state in a lawsuit contesting the state Health Department practice of allowing infant blood samples to be used for research purposes without getting permission to do so.

Advertisement | View Media Kit

 

The majority opinion reverses a 2009 summary judgment that had been in favor of the state, which allows Mayo Medical Laboratories to use for research excess blood samples taken as part of a state contract to perform screening tests for inherited and congenital diseases, according to the ruling. (The lab is part of Mayo Clinic's department of laboratory medicine and pathology, according to its website.)

An appeal of the summary judgment was denied in 2010.

As a result of the ruling, the state will now have to get written, informed consent before the samples can be used for research, said Scott Kelly, an attorney for the plaintiffs who works for Farrish Johnson Law Office, Mankato, Minn.

In addition, the ruling could have implications for several other states that have programs similar to Minnesota's, Kelly said.

The state is considering its options. “We are reviewing the court's decision to determine the potential implications of the ruling on the ongoing operations of the state's newborn screening program,” Dr. Ed Ehlinger, Minnesota commissioner of health, said in a statement.

“This important public health program protects Minnesota babies from serious congenital and heritable disorders,” Ehlinger said.

Kelly said it's unclear whether Minnesota is in a position to profit from the research, but since it is in the screening contract, it may affect the pricing for the program.

The state Supreme Court majority opinion concluded that the screening program's blood samples are considered to be genetic information and therefore subject to a state law restricting use of genetic data, one of the issues that was the basis of the lower courts' decisions to grant summary judgment in favor of the state.

A minority opinion disagreed with the ruling that the blood samples were genetic information.

The majority opinion also found that the state is not expressly provided with the authority to collect the data, but did not rule on an issue regarding the remedies that would be provided to the plaintiffs—nine families with 25 children born between 1998 and 2008—and sent that portion of the suit back to state district court.


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...

Search ModernHealthcare.com:



Daily Dose MH Alert MH AM HITS Modern Physician Most Requested Advance Notice

LinkedIn Amazon Kindle Twitter Facebook Flickr News Feeds